Extra ₹100 off on medicines

Dengue Vaccine in India: Approval, Eligibility, Safety & Effectiveness

Last Updated: November 19, 2026

Share
Dengue Vaccine in India: Approval, Eligibility, Safety & Effectiveness

Last updated on:19-Nov-2026

Summary

The dengue vaccine in India is, for now, one product: Qdenga. India's drug regulator, CDSCO, allowed it to be imported in July 2026 for people aged 4 to 60. It is given as two injections, three months apart, by a doctor or nurse — you cannot buy or give it yourself. It lowers the chance of dengue and of a hospital stay, but it does not stop every case.

Key Takeaways

  • What it is: A live, weakened vaccine that helps protect against dengue, a mosquito-borne viral fever.
  • Active ingredients: Weakened dengue virus types 1, 2, 3 and 4.
  • Used for: Preventing dengue in people aged 4 to 60 years.
  • Not meant for: Children under 4, adults over 60, pregnancy, breastfeeding, or a weak immune system.
  • Prescription: Given only by a doctor or nurse at a clinic; it is not for self-use.
  • How to take: Two injections, three months apart, under the skin of the upper arm.
  • Common side effects: Pain or redness at the injection site, headache, muscle pain and tiredness; usually mild.

What Is the Dengue Vaccine?

Dengue is a viral fever spread by Aedes mosquitoes, which bite mostly during the day. A vaccine trains your immune system to fight the virus before you meet it. Qdenga is the dengue vaccine that India's drug regulator, CDSCO, has cleared to be brought into the country and used here. That clearance is called an import permission, and it is not the same as the vaccine already being in your local clinic. It contains weakened versions of all four dengue types.

Qdenga Composition (Per Dose)

IngredientTypeWhat it does (in simple words)
Dengue virus type 1, weakenedLive vaccine virusTeaches the body to fight dengue type 1
Dengue virus type 2, weakenedLive vaccine virusTeaches the body to fight dengue type 2
Dengue virus type 3, weakenedLive vaccine virusTeaches the body to fight dengue type 3
Dengue virus type 4, weakenedLive vaccine virusTeaches the body to fight dengue type 4

You do not choose a strength. The clinic prepares a standard dose from the manufacturer's pack.

How Does the Dengue Vaccine Work?

Think of it as a practice drill for your immune system:

  1. Show the shape: The weakened viruses look like real dengue virus.
  2. Build antibodies: Your body makes antibodies against all four types.
  3. Keep the memory: If real dengue virus enters later, these antibodies attack it early.

The weakened viruses cannot cause dengue.

Uses of the Dengue Vaccine

Doctors can give the dengue vaccine to prevent dengue, not to treat it. It is given for:

  • Dengue prevention in people aged 4 to 60 years.
  • Fewer hospital stays from dengue.
  • People who had dengue before, because a second infection can be more serious.
  • People who never had dengue, who can be vaccinated without a blood test.

It does not treat dengue you already have, and it does not prevent every case.

Is the Dengue Vaccine Approved in India?

Yes. On 14 July 2026, CDSCO gave Takeda's dengue vaccine an import permission for people aged 4 to 60 years. The permission number is IMP/BIO/26/000087.

On 19 March 2026, CDSCO's vaccine expert committee recommended the permission. It asked the company to study the vaccine's safety and effectiveness in Indian people. That study must be done within six months of the vaccine reaching the market. The Indian trial included 480 healthy people aged 4 to 60, and the committee found the vaccine was tolerated well.

As of September 2026, it is the only dengue vaccine in CDSCO's import permission list. Ask your doctor or hospital whether doses are available near you.

Qdenga vs Dengvaxia: What Is the Difference?

Dengvaxia is an older dengue vaccine. India's vaccine committee did not clear it in 2021.

QdengaDengvaxia
Cleared for import in IndiaYes, July 2026No record in the current list
Blood test before vaccinationNot neededNeeded, to confirm past dengue
Who can get itPeople with or without past dengueOnly people who had dengue before
Doses2, three months apartNot used in India

In July 2021, CDSCO's vaccine expert committee put Sanofi's application on hold. It asked the company to identify dengue-prone areas from an ICMR survey and to give full details of a test that proves past dengue, which India did not have then. As of September 2026, no approval for Dengvaxia appears in CDSCO's import-permission list.

Who Can Get the Dengue Vaccine in India?

India's approval covers people aged 4 to 60 years. The World Health Organization's advice for national immunisation programmes is narrower. It recommends the vaccine for children aged 6 to 16 in areas where dengue spreads heavily. For people aged 17 to 60, it allows the vaccine only if they have another health condition that raises their risk, and only where severe dengue is a recorded problem in that country.

AgeApproved in IndiaAdvice for public programmes
Under 4NoNo
4 to 5YesNot for routine use
6 to 16YesRecommended where dengue is common
17 to 60YesOnly for people with other health conditions
Over 60NoNo

You do not need a blood test to show past dengue. Dengvaxia is different: it is given only to people with a confirmed past infection.

Dengue Vaccine Schedule: How Many Doses?

Two doses, three months apart. A doctor or nurse injects the vaccine under the skin of the upper arm. Both doses are needed to complete the course. Do not shorten the gap between doses.

If you miss the second dose, get it as soon as you can. You do not need to start the course again.

How Well Does the Dengue Vaccine Work?

In the main trial, which was in children aged 4 to 16, the vaccine cut confirmed dengue by about 80 in every 100 cases. That result was measured in the year after the second dose. It also reduced the number of people admitted to hospital with dengue by about 90 in every 100, measured over the 18 months after the second dose.

Evidence in adults is weaker. Far fewer adults were studied, so doctors are less sure how well the vaccine works after the teenage years.

Protection is not the same for everyone. It is stronger in people who had dengue before. In people who never had dengue, it protects well against types 1 and 2. Protection against types 3 and 4 is not clear. Experts are still learning how long protection lasts.

Side Effects of the Dengue Vaccine

Most people have only mild problems.

Common and mild:

  • Pain, redness or swelling where the needle went in
  • Headache
  • Muscle pain
  • Feeling tired or unwell
  • Mild fever, in up to 1 in 10 people

These usually settle within a few days and are less common after the second dose.

Rare but serious:

  • A severe allergic reaction, with swelling of the face or lips, trouble breathing, a widespread rash or fainting
  • A serious infection, which is a risk if your immune system is weak
  • Feeling faint or dizzy soon after the injection - sit or lie down and tell the nurse

A severe allergic reaction needs emergency care. Call 112, or 108 for an ambulance.

Who Should Not Take the Dengue Vaccine

  • Anyone who had a severe allergic reaction to a previous dose
  • People with a weak immune system from illness or medicines, including HIV
  • Women who are pregnant, or who plan pregnancy within a month
  • Women who are breastfeeding
  • Children under 4 and adults over 60

Precautions

Tell your doctor before taking the vaccine if you:

  • Have HIV, or take steroids, chemotherapy or other medicines that weaken immunity
  • Are pregnant, may be pregnant, or plan a pregnancy within a month
  • Are breastfeeding

Drug Interactions

Medicine or vaccineWhat can happen
Yellow fever vaccineCan be given at the same visit
Hepatitis A vaccineCan be given at the same visit
HPV vaccineBeing studied; ask your doctor about timing
Chemotherapy or high-dose steroidsVaccine may not work; a live vaccine can cause serious infection
Medicines for transplant or autoimmune diseaseSame risk; tell your doctor first

Always tell your doctor about every medicine, supplement or vaccine you have had recently.

Storage

The clinic keeps the vaccine in a refrigerator as part of its cold chain. You do not need to store it at home.

Frequently Asked Questions About the Dengue Vaccine

When to See a Doctor

See a doctor right away if, after the injection, you have:

  • Swelling of the face, lips or tongue
  • Trouble breathing or wheezing
  • A fast-spreading rash with dizziness or fainting
  • A fever that does not settle

Dengue can still happen after vaccination. Go to hospital for high fever with severe belly pain, constant vomiting or bleeding gums. Also go if you feel very weak after the fever drops.

The Bottom Line

The dengue vaccine is a useful new tool for India. It lowers the chance of dengue and of a hospital stay. India's import permission covers people aged 4 to 60, and it is given as two injections three months apart. Most side effects are mild and settle in a few days. It does not replace mosquito control.

editorial-png
Authentic & trustworthy information
Having issues with the content?
Report Error

Add PlatinumRx as a preferred source on Google